M
Myriad Genetics IncMYGN
Myriad Genetics is a leading molecular diagnostic and precision medicine company committed to advancing health and well-being for all. Myriad Genetics develops and commercializes molecular tests that help patients and providers uncover genetic insights. Our tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where molecular insights can significantly improve patient care, support earlier detection, enable more precise treatment and contribute to lowering healthcare.
US StocksHealthcareSmall CapLow Volatility / Defensive
MYGN の価格トレンド
Myriad Genetics Inc · TradingView フルチャート
NASDAQ:MYGN